139 related articles for article (PubMed ID: 10357256)
1. Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors.
Krowicki ZK; Moerschbaecher JM; Winsauer PJ; Digavalli SV; Hornby PJ
Eur J Pharmacol; 1999 Apr; 371(2-3):187-96. PubMed ID: 10357256
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake KD; Compton DR; Varga K; Martin BR; Kunos G
J Pharmacol Exp Ther; 1997 Jun; 281(3):1030-7. PubMed ID: 9190833
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets.
Partosoedarso ER; Abrahams TP; Scullion RT; Moerschbaecher JM; Hornby PJ
J Physiol; 2003 Jul; 550(Pt 1):149-58. PubMed ID: 12879865
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
Adams MD; Chait LD; Earnhardt JT
Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
[TBL] [Abstract][Full Text] [Related]
5. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat.
Krowicki ZK; Hornby PJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):214-21. PubMed ID: 10734172
[TBL] [Abstract][Full Text] [Related]
6. Involvement of hindbrain and peripheral prostanoids in gastric motor and cardiovascular responses to delta-9-tetrahydrocannabinol in the rat.
Krowicki ZK
J Physiol Pharmacol; 2012 Dec; 63(6):581-8. PubMed ID: 23388474
[TBL] [Abstract][Full Text] [Related]
7. The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase.
O'Sullivan SE; Randall MD; Gardiner SM
J Pharmacol Exp Ther; 2007 May; 321(2):663-72. PubMed ID: 17284670
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
9. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
10. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
Shivachar AC; Martin BR; Ellis EF
Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
Järbe TU; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
[TBL] [Abstract][Full Text] [Related]
13. Gastric motor and cardiovascular effects of insulin in dorsal vagal complex of the rat.
Krowicki ZK; Nathan NA; Hornby PJ
Am J Physiol; 1998 Nov; 275(5):G964-72. PubMed ID: 9815025
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
[TBL] [Abstract][Full Text] [Related]
15. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
[TBL] [Abstract][Full Text] [Related]
16. Opposing gastric motor responses to TRH and substance P on their microinjection into nucleus raphe obscurus of rats.
Krowicki ZK; Hornby PJ
Am J Physiol; 1993 Nov; 265(5 Pt 1):G819-30. PubMed ID: 7694501
[TBL] [Abstract][Full Text] [Related]
17. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
Shen M; Thayer SA
Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Cox ML; Welch SP
Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.
Vidrio H; Sánchez-Salvatori MA; Medina M
J Cardiovasc Pharmacol; 1996 Aug; 28(2):332-6. PubMed ID: 8856492
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
Wagner JA; Járai Z; Bátkai S; Kunos G
Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
